Today the Food and Drug Administration (FDA) approved the use of the Pfizer-BioNTech COVID-19 booster vaccine in adolescents ages 16 and 17.The group will be eligible through an emergency use authorization (EUA) for a third dose of the mRNA vaccine 6 months after their initial vaccination series.
Acting FDA Commissioner Janet Woodcock, MD, said the announcement will come in time to protect families during the holidays."As people gather indoors with family and friends for the holidays, we can't let up on all the preventive public health measures that we have been taking during the pandemic.
With both the delta and omicron variants continuing to spread, vaccination remains the best protection against COVID-19," Woodcock said in a press